BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26942192)

  • 1. E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.
    Rogers JH; Owens KS; Kurkewich J; Klopfenstein N; Iyer SR; Simon MC; Dahl R
    Biomed Res Int; 2016; 2016():3983686. PubMed ID: 26942192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembling a gene regulatory network for specification of the B cell fate.
    Medina KL; Pongubala JM; Reddy KL; Lancki DW; Dekoter R; Kieslinger M; Grosschedl R; Singh H
    Dev Cell; 2004 Oct; 7(4):607-17. PubMed ID: 15469848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
    Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
    Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation.
    McIvor Z; Hein S; Fiegler H; Schroeder T; Stocking C; Just U; Cross M
    Exp Hematol; 2003 Jan; 31(1):39-47. PubMed ID: 12543105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12.
    Kee BL; Murre C
    J Exp Med; 1998 Aug; 188(4):699-713. PubMed ID: 9705952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.
    Voronova AF; Lee F
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Threshold Levels of Gfi1 Maintain E2A Activity for B Cell Commitment via Repression of Id1.
    Fraszczak J; Helness A; Chen R; Vadnais C; Robert F; Khandanpour C; Möröy T
    PLoS One; 2016; 11(7):e0160344. PubMed ID: 27467586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.
    Nerlov C; Graf T
    Genes Dev; 1998 Aug; 12(15):2403-12. PubMed ID: 9694804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PU.1 Is Required for the Developmental Progression of Multipotent Progenitors to Common Lymphoid Progenitors.
    Pang SHM; de Graaf CA; Hilton DJ; Huntington ND; Carotta S; Wu L; Nutt SL
    Front Immunol; 2018; 9():1264. PubMed ID: 29942304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRF8 regulates B-cell lineage specification, commitment, and differentiation.
    Wang H; Lee CH; Qi C; Tailor P; Feng J; Abbasi S; Atsumi T; Morse HC
    Blood; 2008 Nov; 112(10):4028-38. PubMed ID: 18799728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells.
    Zou GM; Chen JJ; Yoder MC; Wu W; Rowley JD
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13236-41. PubMed ID: 16141339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multitalented E2A: a new role in lymphoid-lineage priming.
    Kondo M
    Immunity; 2008 Aug; 29(2):169-70. PubMed ID: 18701077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch signaling induces multilineage myeloid differentiation and up-regulates PU.1 expression.
    Schroeder T; Kohlhof H; Rieber N; Just U
    J Immunol; 2003 Jun; 170(11):5538-48. PubMed ID: 12759431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1.
    Zhang P; Behre G; Pan J; Iwama A; Wara-Aswapati N; Radomska HS; Auron PE; Tenen DG; Sun Z
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8705-10. PubMed ID: 10411939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors.
    Scott EW; Fisher RC; Olson MC; Kehrli EW; Simon MC; Singh H
    Immunity; 1997 Apr; 6(4):437-47. PubMed ID: 9133423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcriptional repressor GFI-1 antagonizes PU.1 activity through protein-protein interaction.
    Dahl R; Iyer SR; Owens KS; Cuylear DD; Simon MC
    J Biol Chem; 2007 Mar; 282(9):6473-83. PubMed ID: 17197705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP; Walsh JC; Singh H
    EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A.
    O'Riordan M; Grosschedl R
    Immunity; 1999 Jul; 11(1):21-31. PubMed ID: 10435576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIR-23A microRNA cluster inhibits B-cell development.
    Kong KY; Owens KS; Rogers JH; Mullenix J; Velu CS; Grimes HL; Dahl R
    Exp Hematol; 2010 Aug; 38(8):629-640.e1. PubMed ID: 20399246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates.
    Walsh JC; DeKoter RP; Lee HJ; Smith ED; Lancki DW; Gurish MF; Friend DS; Stevens RL; Anastasi J; Singh H
    Immunity; 2002 Nov; 17(5):665-76. PubMed ID: 12433372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.